Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

PHAXIAM Therapeutics (Euronext: PHXM FR001400K4B1), a biopharmaceutical company ("the Company" or "PHAXIAM") developing innovative treatments for severe and resistant bacterial ...

Shares of Liminatus Pharma rose in post-market trading after the pre-clinical stage biopharmaceutical company said it regained compliance with Nasdaq listing requirements. The stock rallied 77% to $22 ...

RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological ...

Biodexa Pharmaceuticals ( ($BDRX) ) just unveiled an announcement. On June 4, 2025, Biodexa Pharmaceuticals announced the recruitment of the first ...

XP 8121 is a combination drug meant to better control hypothyroidism, in part by moving its common therapy, levothyroxine, ...

Thermo Fisher Scientific launched two advanced mass spectrometers and emphasized its multi-omics strategy during the American ...

McKesson Corp. has announced plans to separate its Medical-Surgical Solutions segment into an independent company. This strategic move is aimed at sharpening McKesson’s focus on higher-growth, higher- ...

Cold chain monitoring solutions have become indispensable to the biopharma business for managing complicated supply chains.

Bristol-Myers Squibb Company (NYSE:BMY), which focuses on innovative cancer and immunology treatments, is a leader in the ...

Sanofi S.A. (Paris, France) and Blueprint Medicines Corp. (Blueprint), a U.S.-based, publicly traded biopharmaceutical company specializing in systemic ...